Skip to main content
logo
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
167.29
+2.80 (1.70%)
At close: Feb 2, 2026, 4:00 PM EST
168.00
+0.71 (0.42%)
After-hours: Feb 2, 2026, 4:51 PM EST

Jazz Pharmaceuticals Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Neuroscience
2.82B2.75B2.72B2.70B2.66B2.63B2.64B2.71B
Neuroscience Growth
6.01%4.40%3.25%-0.35%-3.68%-5.92%-5.85%-1.92%
Oncology
1.08B1.08B1.08B1.11B1.09B1.07B1.04B1.02B
Oncology Growth
-0.93%1.04%3.77%9.47%13.26%15.16%15.23%16.18%

Oncology Revenue Breakdown

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Rylaze Enrylaze
396.25M395.16M402.33M410.85M411.11M417.19M411.05M394.23M------
Rylaze Enrylaze Growth
-3.61%-5.28%-2.12%4.22%10.08%21.95%31.17%39.97%------
Zepzelca
295.20M301.75M308.25M320.32M316.00M308.15M297.45M289.53M--
Zepzelca Growth
-6.58%-2.08%3.63%10.63%9.92%10.13%7.09%7.27%--
Defitellio Defibtrotide
198.17M212.24M209.55M216.57M210.00M191.91M192.60M184.00M
Defitellio Defibtrotide Growth
-5.63%10.59%8.80%17.70%20.99%9.48%4.74%-5.30%
Vyxeos
165.23M161.96M160.12M162.60M156.26M151.77M142.82M147.50M
Vyxeos Growth
5.74%6.71%12.11%10.24%19.42%15.78%9.09%15.25%
Erwinaze
-----------------146.10M150.47M147.14M

Neroscience Revenue Breakdown

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Xywav
1.59B1.55B1.50B1.47B1.41B1.35B1.31B1.27B---
Xywav Growth
13.00%14.58%14.67%15.73%15.77%18.46%24.80%32.82%---
Epidiolex
1.05B996.07M991.44M972.42M938.00M900.15M855.28M845.47M-----
Epidiolex Growth
11.63%10.66%15.92%15.02%15.54%13.32%11.45%14.81%-----
Xyrem
157.54M179.99M206.83M233.82M291.25M358.24M455.83M569.73M
Xyrem Growth
-45.91%-49.76%-54.63%-58.96%-59.01%-57.42%-52.07%-44.17%
Sunosi
-------------63.03M62.19M57.91M51.70M41.56M38.02M28.33M
Sunosi Growth
-------------51.65%63.58%104.40%----
Sativex
19.95M19.78M21.55M18.88M18.84M18.88M15.31M19.67M-----
Sativex Growth
5.87%4.76%40.80%-4.02%-2.13%5.81%-20.21%16.90%-----
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.